Integrated ATPS-LFA Analyte Concentration for Point-of-Care Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing lateral flow assays (LFAs) face limitations in sensitivity and efficiency for detecting and quantifying target analytes, particularly in point-of-care settings, where they often require complex equipment and trained personnel, and struggle with environmental variability.
Innovation Solution
Integration of aqueous two-phase systems (ATPS) with LFAs to enhance analyte concentration and detection, allowing for simplified, portable devices that operate across varying environmental conditions, achieving sensitivity comparable to lab-based assays like ELISA.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of operation
If lateral flow assays are used for point-of-care detection, then portability and ease of operation are improved, but sensitivity and measurement precision deteriorate
Solution Approach 1:
The patent applies preliminary action by incorporating magnetic beads that pre-concentrate target analytes from the sample before the lateral flow detection step. This pre-concentration occurs as the sample flows through the test strip, allowing the LFA to achieve enhanced sensitivity without compromising its portability or ease of operation. The magnetic beads are positioned in advance to capture and concentrate analytes, making them more detectable in subsequent steps.
Solution Approach 2:
The patent uses magnetic beads as an intermediary substance between the sample and the detection system. These beads bind to target analytes and facilitate their concentration and transport to the detection zone. This intermediary mechanism enables the LFA to achieve sensitivity comparable to laboratory-based assays while maintaining the simplicity and portability characteristic of point-of-care devices.
2Device complexity
If conventional LFA methods are used, then device simplicity is improved, but detection sensitivity and quantification accuracy worsen
Solution Approach 1:
The patent merges two previously separate functions into a single integrated device: the magnetic bead-based analyte concentration function and the lateral flow detection function. This integration allows the device to maintain simplicity and portability while achieving enhanced detection sensitivity. The magnetic beads, detection antibodies, and readout mechanisms are combined in one device, eliminating the need for separate concentration and detection steps.
Solution Approach 2:
Magnetic beads serve as an intermediary that bridges the gap between simple device design and high detection sensitivity. By introducing these beads as a mediating element, the patent enables analyte concentration without adding complex external equipment, thus maintaining device simplicity while improving detection capabilities.
3Speed
If LFA is used without analyte concentration, then operation speed is improved, but detection limit and sensitivity worsen
Solution Approach 1:
The patent implements preliminary action by incorporating analyte concentration mechanisms that occur simultaneously with or before the lateral flow migration. Magnetic beads pre-concentrate analytes as the sample flows through the test strip, ensuring that concentration happens in advance of the detection step. This allows rapid operation without sacrificing detection sensitivity, as the concentration process is integrated into the flow path rather than requiring separate time-consuming steps.
Solution Approach 2:
The patent maintains continuity of useful action by integrating the concentration and detection processes into a continuous flow system. As the sample flows continuously through the lateral flow strip, magnetic beads continuously concentrate analytes along the flow path, eliminating idle time between concentration and detection. This continuous operation preserves speed while achieving enhanced sensitivity through ongoing analyte concentration.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The integration of ATPS with LFAs provides a robust, versatile, and cost-effective method for detecting and quantifying target analytes with improved sensitivity, requiring minimal training and equipment, and maintaining accuracy in diverse environments.
Implementation Method 1
a target analyte is concentrated by partitioning into a first phase solution or at an interface between the first phase solution and a second phase solution
Implementation Method 2
lateral flow assay (LFA) technology
Data Source
AI summary
Disclosed herein are devices and methods that use aqueous two phase systems and lateral flow assays to detect target analytes in a sample. These devices and methods may be used to diagnose a disease or condition in a biological sample, such as blood or serum. In addition, these devices and methods may be used to detect allergens in a food samples or contaminants, such as environmental toxins, in water samples. Device and kit components may be conveniently assembled in a portable container and are amenable to actuation in most settings. The devices are simple to use, requiring a non-trained operator to simply add the sample to the device. Conveniently, the time it takes to detect the target analyte is very short. Thus, the devices and methods disclosed herein provide novel and useful means for point-of-care.